Ombitasvir/paritaprevir/ritonavir and dasabuvir

Details

Files
Generic Name:
Ombitasvir/paritaprevir/ritonavir and dasabuvir
Project Status:
Complete
Therapeutic Area:
Hepatitis C, chronic
Manufacturer:
AbbVie Corporation
Call for patient/clinician input open:
Brand Name:
Holkira Pak
Project Line:
Reimbursement Review
Project Number:
SR0406-000
Call for patient/clinician input closed:
NOC Status at Filing:
Pre NOC
Performance Metric:
Achieved
Submission Type:
Initial
Indications:
Hepatitis C, chronic
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation: